Indepth Analysis and Report for Russian Pharmaceutical Sector
Description of Project
Chaucer were invited to prepare and deliver an in-depth analysis and report into the current Russian Pharmaceutical Sector with a specific focus on Manufacturing and the anticipated changes in response to the publication of the Pharma 2020 strategy paper by the Russian Government.
The objective was to assist in the development of a manufacturing strategy for a Major Global Pharmaceutical Company operating in Russia within the context of rapid growth in the pharmaceutical market and the actual and anticipated changes in the regulatory environment aimed at encouraging local Russian production.
Given the broad depth of experience in the Pharmaceutical Industry and an impressive contact portfolio, Chaucer were able to provide the customer with up-to-date knowledge of the Russian pharmaceutical market: the key participants, local production sites, production cycles, and the differing strategies adopted by various international and Russian organisations in order to address the expected changes.
All of this was conducted within the context of the challenges facing an emerging and growing market, in particular, the lack of transparency in purchasing procedures, counterfeit drugs and unclear legislation on intellectual property protection. The study and subsequent presentation included an insight into local business rules and habits.
Our network of pharmaceutical clients and our position as a trusted partner allowed us to easily reach out and engage in an open and transparent dialogue as part of a benchmarking study with 43 of the major international and Russian pharmaceutical companies operating in Russia. The analysis used our proprietary benchmarking methodology and included telephone interviews, questionnaires, conference talks and informal conversations.
Chaucer’s Scope:
- Benchmarking Study of international and Russian pharmaceutical companies operating and either manufacturing or planning to manufacture in Russia
- Political, economic, social, technological and legal context analysis of the Russian pharmaceutical market
- An assessment of the strengths, weaknesses, opportunities, and threats in the context of: competition, new entrants, consumers / buyers, suppliers, substitutes, complementary products, the government and the public, including lobbyists.
- An assessment of different scenarios in a manufacturing context and the likely impact to the Customer’s Business.
- An understanding of the evolving Russian standards and their application of Good Manufacturing Practice (GMP).
- Report with the survey results and recommendations of key points for the Company to address in their manufacturing strategy
Benefits:
A comprehensively exhaustive strategy and benchmarking study gave significant advantage to the Customer as it provided them with clear information about the political, economic, social, technological and legal context and assisted them in clarifying an often ambiguous and uncertain environment.
Many of the organisations contacted expressed a lack of awareness or clarity around the eventual impact of the proposed changes under the Government’s strategy. The Report also included an assessment of different scenarios in a manufacturing context and the likely impact to the Customer’s Business and provided valuable input into the development of an effective manufacturing strategy.
-
Development of a three year transition strategy and plan Read more
-
Develop and implement a plan to transform into a world class business Read more
-
Commercial Optimisation Read more
-
Acquisition of a Global Specialised Chemicals Business Read more
-
Change Manage IT Project Management Methodology Read more
- Accreditations/Partners
